The Compound Report is an educational resource. Nothing on this site constitutes medical advice or encourages personal use of any compound. Always consult a qualified healthcare provider.

Educational reference only. Nothing on this page constitutes medical advice or encourages personal use of this compound. Always consult a qualified healthcare provider before any decision involving your health.

KLOW Stack

KPV + GLOW Stack · KLOW Peptide Stack

C
Animal replicated
C
Evidence grade: Animal replicated

Effect demonstrated in multiple animal studies; human data sparse or extrapolated. Grades summarize evidence quality, not whether a compound is appropriate, legal, or risk-free.

At a glance
What it is
KPV + GLOW — Gut/Recovery/Beauty Peptide Stack — Peptide Stack, Gut Barrier Support, Recovery Stack.
Why people use it
Used primarily for gut health and immune support.
What the evidence supports
KLOW is the most expensive stack in this reference for a full cycle. Approximate per-cycle (8 weeks) research-grade costs: GLOW blend (70mg vials × 2-3) = $200-350; KPV separately (50-100mg vial) = $30-60; total KLOW = $230-410 research grade. Clinic prices $600-1500+. Whether the KPV addition justifies the extra cost depends entirely on whether the specific anti-inflammatory or gut dimension is a priority for the individual user. For pure musculoskeletal healing without inflammatory or gut concerns, GLOW at lower cost is the appropriate choice. KLOW is the right stack for the right indication, not a universal upgrade.
If you only read one thing

KLOW is mechanistically the most comprehensive tissue repair protocol in this reference — four non-overlapping mechanisms covering angiogenesis, cell migration, ECM remodeling, and inflammatory suppression simultaneously. The tension: comprehensiveness is not the same as superiority. Adding a fourth compound means: more injections (or more complex blended vial formulation); more copper accumulation risk on extended cycles (GHK-Cu); more cost; and more moving parts when something doesn't work as expected. For many users, GLOW already covers their needs; KLOW is the right choice when the inflammatory dimension or gut protection is a specific priority. The chapter exists to clarify when KLOW is worth the additional complexity.

Route / form

Same compound, route-specific context. Switch forms instead of opening separate pages.

Evidence fit
Route-specific

Use the route notes below to match form, goal, and evidence quality.

Route caveat
Protocol not standardized

No route-matched protocol rows were parsed for this form; use the route notes and full dosing chapter before comparing options.

Protocol anchor
Full dosing section

Open the full report at the dosing chapter for protocol rows, cycle context, and administration notes.

Typical dose snapshot
See route notes
Evidence varies by use case
Evidence reality check
Evidence snapshot
KLOW is the most expensive stack in this reference for a full cycle. Approximate per-cycle (8 weeks) research-grade costs: GLOW blend (70mg vials × 2-3) = $200-350; KPV separately (50-100mg vial) = $30-60; total KLOW = $230-410 research grade. Clinic prices $600-1500+. Whether the KPV addition justifies the extra cost depends entirely on whether the specific anti-inflammatory or gut dimension is a priority for the individual user. For pure musculoskeletal healing without inflammatory or gut concerns, GLOW at lower cost is the appropriate choice. KLOW is the right stack for the right indication, not a universal upgrade.
From the chapter quick-reference block.
Risk posture
No major flags listed
Review route-specific cautions before use.
Properties
Active malignancy: hard stopNot injectable
Evidence
CAnimal replicated
Stack Identity
Type: stack. Slug: klow-stack. stackGrade: C. Components: ghk-cu-injectable + bpc-157 + tb-500 + kpv. KLOW = K(PV) + (G)LOW. The GLOW Stack (GHK-Cu + BPC-157 + TB-500) with KPV added as the fourth component. relatedStacks: glow-stack (subset), wolverine-stack (three-component subset), gut-stack (BPC-157 + KPV subset).
What KPV Adds
KPV (Lys-Pro-Val) is the C-terminal tripeptide of alpha-MSH with selective anti-inflammatory activity (NF-kB suppression, COX-2 inhibition, mast cell stabilization, cytokine reduction) and no melanocortin receptor activity. In the GLOW Stack context: BPC-157 provides local angiogenesis and partial NF-kB suppression; TB-500 provides systemic cell mobilization; GHK-Cu provides ECM remodeling. None of these three specifically addresses: mast cell activity, direct COX-2 inhibition, or gut mucosal inflammatory signaling. KPV adds these dimensions without overlapping with the other three components.
The Gut Dimension
KPV has specific gut mucosal anti-inflammatory activity (Kannengiesser 2008: IBD models; NF-kB in intestinal epithelial cells and macrophages). BPC-157 already has gut protection (angiogenesis, tight junction reinforcement). KPV + BPC-157 together = the Gut Stack within the KLOW Stack. This means KLOW simultaneously provides musculoskeletal healing, ECM remodeling, and gut protection — the broadest-spectrum repair protocol in this reference.
stackGrade C
The combination has zero published studies of any kind. All four components have individual animal evidence (Grade C) and community evidence (Grade E). The combination grade is C — assigned from the individual component evidence, not from combination data that does not exist. Four well-mechanized compounds combined without a single combination study.
Active Malignancy: Hard Stop
GHK-Cu's VEGF angiogenic mechanism applies to the entire KLOW Stack, as it does for GLOW. BPC-157 and TB-500 add their own angiogenic and progenitor cell mobilization cautions. KPV does not add a cancer concern. The combined stack's active malignancy status = hard stop (GHK-Cu drives this; same as GLOW).
Simple view

Need the deep dive?

The default page keeps the decision layer visible first: summary, routes, evidence, and risks. Open the full report for mechanisms, chapter sections, citations, updates, and print/share controls.

Check interactions